Compugen to Participate in Stifel 2024 Healthcare Conference
Provided By PR Newswire
Last update: Nov 11, 2024
HOLON, Israel, Nov. 11, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that Compugen management will participate in a fireside chat at the upcoming Stifel 2024 Healthcare Conference in New York City. The fireside chat will take place on Monday, November 18, 2024 at 8:35 am ET.
Read more at prnewswire.comNASDAQ:CGEN (7/15/2025, 8:00:00 PM)
1.58
-0.01 (-0.63%)
Find more stocks in the Stock Screener
